Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension
出版年份 2019 全文链接
标题
Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension
作者
关键词
-
出版物
Clinical and Experimental Optometry
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-01-09
DOI
10.1111/cxo.12853
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies
- (2018) Megan E. Cavet et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Latanoprostene bunod ophthalmic solution 0.024% for IOP lowering in glaucoma and ocular hypertension
- (2017) Paul L. Kaufman EXPERT OPINION ON PHARMACOTHERAPY
- Aqueous outflow - A continuum from trabecular meshwork to episcleral veins
- (2017) Teresia Carreon et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis
- (2017) Seth R Flaxman et al. Lancet Global Health
- Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study
- (2016) Kazuhide Kawase et al. ADVANCES IN THERAPY
- Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours
- (2016) John H.K. Liu et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study
- (2016) Felipe A. Medeiros et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension
- (2016) Robert N. Weinreb et al. OPHTHALMOLOGY
- Primary Open-Angle Glaucoma Preferred Practice Pattern® Guidelines
- (2016) Bruce E. Prum et al. OPHTHALMOLOGY
- Practice patterns and treatment changes for open-angle glaucoma: the RiGOR study
- (2016) Anne L Coleman et al. Journal of Comparative Effectiveness Research
- Evaluation of the Effect of Latanoprostene Bunod Ophthalmic Solution, 0.024% in Lowering Intraocular Pressure over 24 h in Healthy Japanese Subjects
- (2015) Makoto Araie et al. ADVANCES IN THERAPY
- Glaucoma treatment: by the highest level of evidence
- (2015) Anders Heijl LANCET
- Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
- (2015) David F Garway-Heath et al. LANCET
- Prevalence, Risk Factors, and Visual Features of Undiagnosed Glaucoma
- (2015) Jacqueline Chua et al. JAMA Ophthalmology
- Burden of Undetected and Untreated Glaucoma in the United States
- (2014) Yahya Shaikh et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
- (2014) Robert N Weinreb et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility
- (2014) W. Michael Dismuke et al. EXPERIMENTAL EYE RESEARCH
- The Pathophysiology and Treatment of Glaucoma
- (2014) Robert N. Weinreb et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040
- (2014) Yih-Chung Tham et al. OPHTHALMOLOGY
- Population-based glaucoma prevalence studies in Asians
- (2014) Hyun-kyung Cho et al. SURVEY OF OPHTHALMOLOGY
- Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma
- (2014) Emmanuel S. Buys et al. Frontiers in Molecular Neuroscience
- Intraocular pressure reduction with topical medications and progression of normal-tension glaucoma: a 12-year mean follow-up study
- (2013) Martha Kim et al. ACTA OPHTHALMOLOGICA
- Risk Factors for Visual Field Progression in the Low-pressure Glaucoma Treatment Study
- (2012) Carlos Gustavo De Moraes et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- The Changing Face of Primary Open-Angle Glaucoma in the United States: Demographic and Geographic Changes From 2011 to 2050
- (2012) Thasarat S. Vajaranant et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Pathophysiology of Hypertension in the Absence of Nitric Oxide/Cyclic GMP Signaling
- (2012) Robrecht Thoonen et al. CURRENT HYPERTENSION REPORTS
- Current understanding of conventional outflow dysfunction in glaucoma
- (2012) W. Daniel Stamer et al. CURRENT OPINION IN OPHTHALMOLOGY
- An Assessment of the Health and Economic Burdens of Glaucoma
- (2011) Rohit Varma et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating Prostaglandin F2α agonist, in preclinical models
- (2011) Achim H.P. Krauss et al. EXPERIMENTAL EYE RESEARCH
- Risk Factors for Incident Open-angle Glaucoma
- (2007) M. Cristina Leske et al. OPHTHALMOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now